Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards a Consensus on Alzheimer’s Disease Comorbidity?
Iska Avitan, Y. Halperin, Trishna Saha, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4360-4360
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Plasma Caffeine Levels and Risk of Alzheimer’s Disease and Parkinson’s Disease: Mendelian Randomization Study
Susanna C. Larsson, Benjamin Woolf, Dipender Gill
Nutrients (2022) Vol. 14, Iss. 9, pp. 1697-1697
Open Access | Times Cited: 40
Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease
Licong Yang, Yabin Wang, Guodong Zheng, et al.
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124316-124316
Closed Access | Times Cited: 35
Viral Infections, Are They a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 13
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies
Devaraj V. Chandrashekar, Ross A. Steinberg, Derick Han, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9492-9492
Open Access | Times Cited: 22
Addressing the Discrepancies Between Animal Models and Human Alzheimer’s Disease Pathology: Implications for Translational Research
Baruh Polis, Abraham O. Samson
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 4, pp. 1199-1218
Closed Access | Times Cited: 6
Multiple chemical sensitivity: It's time to catch up to the science
John Molot, Margaret Sears, Hymie Anisman
Neuroscience & Biobehavioral Reviews (2023) Vol. 151, pp. 105227-105227
Open Access | Times Cited: 14
Autoimmune Disease Classification Based on PubMed Text Mining
Hadas Samuels, Malki Malov, Trishna Saha, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4345-4345
Open Access | Times Cited: 22
Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China
Xiaoqiang Xiao, Shunju Xiang, Qingya Xu, et al.
Aging Clinical and Experimental Research (2023) Vol. 35, Iss. 3, pp. 659-667
Open Access | Times Cited: 11
Integrative bioinformatic approach reveals novel melatonin-related biomarkers for Alzheimer’s disease
Huaxiong Zhang, Dilmurat Hamit, Qing Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Integrating Bulk and Single-Cell Transcriptomic Data to Identify Ferroptosis-Associated Inflammatory Gene in Alzheimer’s Disease
Huiqin Zhou, Yuting Peng, Xinhua Huo, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 2105-2122
Open Access
Adverse events of celecoxib associated with the central nervous system and cancer: a disproportionality analysis of the FDA adverse event reporting system
Yikuan Du, Mengting Zhang, Mianhai Chen, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Polygenic score analysis identifies distinct genetic risk profiles in Alzheimer’s disease comorbidities
Carlos Hernández, Camilo Villamán, Costin Leu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Feasibility and acceptability of an evidence-based, pilot randomised controlled trial to improve health outcomes and reduce dementia risk in people with osteoarthritis. Study protocol for the Healthy Body & Mind Program (HBMP) (Preprint)
Claire V. Burley, W. Keith Yeates, Kelly A. McLeod, et al.
(2025)
Closed Access
Viral Infections, a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
(2024)
Open Access | Times Cited: 3
Donepezil attenuates progression of cardiovascular remodeling and improves prognosis in spontaneously hypertensive rats with chronic myocardial infarction
Meihua Li, Can Zheng, Toru Kawada, et al.
Hypertension Research (2024) Vol. 47, Iss. 5, pp. 1298-1308
Open Access | Times Cited: 3
Advancements and challenges in mouse models of Alzheimer’s disease
Zhengjiang Qian, Yanjiao Li, Keqiang Ye
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 3
Association Between Cholinesterase Inhibitors and New-Onset Heart Failure in Patients With Alzheimer's Disease: A Nationwide Propensity Score Matching Study
Ming‐Jer Hsieh, Dong‐Yi Chen, Cheng‐Hung Lee, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Helicobacter pylori and Alzheimer’s Disease-Related Metabolic Dysfunction: Activation of TLR4/Myd88 Inflammation Pathway from p53 Perspective and a Case Study of Low-Dose Radiation Intervention
Zhao Ju, Liangfang Shen, Meiling Zhou, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 7, pp. 1065-1081
Closed Access | Times Cited: 13
Mitigation of Memory Impairment with Fermented Fucoidan and λ-Carrageenan Supplementation through Modulating the Gut Microbiota and Their Metagenome Function in Hippocampal Amyloid-β Infused Rats
Ting Zhang, Xuangao Wu, Heng Yuan, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2301-2301
Open Access | Times Cited: 13
Brain dysconnectivity with heart failure
Karsten Mueller, Friederike Thiel, Birol Taskin, et al.
Brain Communications (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 7
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion
Federico Menegon, Fabiola De Marchi, Davide Aprile, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1675-1675
Open Access | Times Cited: 2
Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice
Baruh Polis, Margherita Squillario, Vyacheslav Gurevich, et al.
Neurochemical Research (2022) Vol. 47, Iss. 5, pp. 1255-1268
Closed Access | Times Cited: 9
Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy
John Hovanesian, Inder Paul Singh, Aditi Bauskar, et al.
Current Opinion in Ophthalmology (2023) Vol. 34, Iss. Supplement 1, pp. S1-S13
Open Access | Times Cited: 5
Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer’s disease
Kiira Mäklin, Pasi Lampela, Julian Lin, et al.
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top